Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Oct;150(1):42-8.
doi: 10.1111/j.1365-2249.2007.03453.x. Epub 2007 Jul 5.

Antibodies to selected minor target antigens in patients with anti-neutrophil cytoplasmic antibodies (ANCA)

Affiliations

Antibodies to selected minor target antigens in patients with anti-neutrophil cytoplasmic antibodies (ANCA)

M V Talor et al. Clin Exp Immunol. 2007 Oct.

Abstract

In patients with anti-neutrophil cytoplasmic antibodies (ANCA)-associated vasculitis, indirect immunofluorescence (IF) distinguishes between cytoplasmic (C-ANCA) and perinuclear (P-ANCA) neutrophil staining patterns. In patients with primary systemic vasculitis such as Wegener's granulomatosis, microscopic polyangiitis and Churg-Strauss syndrome, these IF staining patterns correspond broadly with antibodies to the two major antigens: the C-ANCA pattern is associated generally with antibodies to serine protease 3 (PR3) and the P-ANCA pattern with antibodies to myeloperoxidase (MPO). However, some sera positive for ANCA by IF are negative for anti-PR3 and anti-MPO antibodies, suggesting the presence of antibodies to minor antigens of PMN granules. We tested sera from a previously well-defined clinical cohort of patients for antibodies to four possible minor antigens: bactericidal permeability increasing protein, elastase, cathepsin G and lactoferrin. IF-positive (+) sera had significantly higher antibody frequencies to the minor antigens than did the IF-negative (-) sera (P < 0.01). Patients with IF(+) PR3(-)MPO(-) sera showed the most varied reactivity to the minor antigens. Among the IF(+) groups, the IF(+) PR3(+)/MPO(-) sera showed the lowest reactivity to the minor antigens. Patients with well-defined ANCA specificities, e.g. the PR3-ANCA response associated with Wegener's granulomatosis, are less likely than are other patient subsets to have antibodies to minor antigen targets. Autoantibodies to these minor antigens contribute to the overall pattern of ANCA identified by IF and help to explain why the correlation between IF and enzyme immunoassays show discrepancies. While the pathophysiological significance of antibodies to minor target antigens needs further evaluation, they may be markers of inflammation associated with disease processes.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Antibody frequency in patients among the four experimental groups reactive to at least one minor anti-neutrophil cytoplasmic antibodies (ANCA) antigen. The greatest prevalence was found in patients with positive immunofluorescence (IF). Patients with a positive IF and positive serine protease 3 (PR3) had a greater prevalence than patients with a negative IF (P = 0·001). Similar results were found in patients with positive IF and positive myeloperoxidase (MPO). Minor antigens were least prevalent in patients with IF, PR3 and MPO.
Fig. 2
Fig. 2
Antibody reactivity to the individual anti-neutrophil cytoplasmic antibodies (ANCA) minor antigens. Patients with immunofluorescence (IF)-positive/myeloperoxidase (MPO)/serine protease 3 (PR3)-negative showed the highest reactivity to all four minor antigens. Antibodies to cathepsin G were most frequently present in all groups. n = number of individuals in a group with antibodies to each minor antigen.

Similar articles

Cited by

References

    1. Van Der Woude FJ, Rassmussen N, Lobatto S, et al. Autoantibodies to neutrophils and monocytes: a new tool for diagnosis and a marker for disease activity in Wegener's granulomatosis. Lancet. 1985;1:425–9. - PubMed
    1. Stone JH, Talor M, Stebbing J, et al. Test characteristics of immunofluorescence and ELISA tests in 856 consecutive patients with possible ANCA-associated conditions. Arthritis Care Res. 2000;13:424–34. - PubMed
    1. Falk RJ, Jennette JC. Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med. 1988;318:1651–7. - PubMed
    1. Hoffman GS, Specks U. Antineutrophil cytoplasmic antibodies. Arthritis Rheum. 1998;41:1521–37. - PubMed
    1. Savige JA, Davies DJ, Gatenby PA. Anti-neutrophil cytoplasmic antibodies (ANCA). their detection and significance: report from workshops. Pathology. 1994;26:186–93. - PubMed

Publication types

MeSH terms